Extendicare Historical Financial Ratios

EXE Stock  CAD 10.38  0.04  0.39%   
Extendicare is recently reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 7.29 or Days Sales Outstanding of 37.0 will help investors to properly organize and evaluate Extendicare financial condition quickly.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Extendicare Financial Ratios Analysis

ExtendicareFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Extendicare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Extendicare financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Extendicare history.

Extendicare Financial Ratios Chart

At this time, Extendicare's EV To Sales is very stable compared to the past year. As of the 23rd of November 2024, ROIC is likely to grow to 0.23, while Price To Sales Ratio is likely to drop 0.43.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Extendicare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Extendicare sales, a figure that is much harder to manipulate than other Extendicare multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Extendicare. There are two different methods for calculating Extendicare invested capital: operating approach and financing approach. Understanding Extendicare invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most ratios from Extendicare's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Extendicare current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Extendicare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Extendicare's EV To Sales is very stable compared to the past year. As of the 23rd of November 2024, ROIC is likely to grow to 0.23, while Price To Sales Ratio is likely to drop 0.43.
 2021 2022 2023 2024 (projected)
Dividend Yield0.06540.07290.06630.0746
Price To Sales Ratio0.540.480.470.43

Extendicare fundamentals Correlations

-0.68-0.27-0.580.170.0-0.54-0.21-0.270.75-0.02-0.320.420.430.22-0.66-0.220.05-0.42-0.090.12-0.430.250.43-0.280.29
-0.680.02-0.06-0.810.140.390.170.02-0.550.240.3-0.2-0.40.030.540.14-0.040.260.05-0.140.27-0.16-0.410.150.02
-0.270.020.290.19-0.26-0.120.251.0-0.42-0.240.20.380.21-1.00.180.040.45-0.060.190.19-0.05-0.06-0.120.53-0.97
-0.58-0.060.290.56-0.180.310.080.29-0.18-0.230.3-0.470.02-0.270.390.12-0.220.210.14-0.120.22-0.02-0.270.07-0.3
0.17-0.810.190.56-0.16-0.03-0.040.190.18-0.28-0.15-0.040.32-0.23-0.280.020.11-0.050.02-0.05-0.05-0.060.31-0.05-0.22
0.00.14-0.26-0.18-0.160.73-0.84-0.260.070.99-0.61-0.39-0.050.280.35-0.810.250.13-0.690.010.10.16-0.360.080.26
-0.540.39-0.120.31-0.030.73-0.42-0.12-0.40.72-0.26-0.6-0.140.150.53-0.350.250.48-0.46-0.230.46-0.1-0.350.120.12
-0.210.170.250.08-0.04-0.84-0.420.25-0.38-0.810.660.43-0.03-0.27-0.360.960.090.110.73-0.210.15-0.40.51-0.1-0.25
-0.270.021.00.290.19-0.26-0.120.25-0.42-0.240.20.380.21-1.00.180.040.45-0.060.190.19-0.05-0.06-0.120.53-0.97
0.75-0.55-0.42-0.180.180.07-0.4-0.38-0.420.04-0.220.030.310.4-0.31-0.35-0.35-0.34-0.110.23-0.350.480.06-0.260.44
-0.020.24-0.24-0.23-0.280.990.72-0.81-0.240.04-0.56-0.36-0.060.270.38-0.80.230.18-0.680.020.140.18-0.40.10.25
-0.320.30.20.3-0.15-0.61-0.260.660.2-0.22-0.560.2-0.14-0.19-0.060.6-0.130.080.84-0.040.110.130.07-0.19-0.23
0.42-0.20.38-0.47-0.04-0.39-0.60.430.380.03-0.360.20.16-0.43-0.610.270.43-0.230.40.04-0.22-0.020.52-0.01-0.39
0.43-0.40.210.020.32-0.05-0.14-0.030.210.31-0.06-0.140.16-0.24-0.16-0.10.080.00.03-0.07-0.010.190.130.01-0.03
0.220.03-1.0-0.27-0.230.280.15-0.27-1.00.40.27-0.19-0.43-0.24-0.11-0.06-0.470.07-0.22-0.180.070.070.05-0.50.97
-0.660.540.180.39-0.280.350.53-0.360.18-0.310.38-0.06-0.61-0.16-0.11-0.39-0.220.11-0.360.140.10.21-0.930.48-0.13
-0.220.140.040.120.02-0.81-0.350.960.04-0.35-0.80.60.27-0.1-0.06-0.39-0.040.160.66-0.30.19-0.470.55-0.21-0.05
0.05-0.040.45-0.220.110.250.250.090.45-0.350.23-0.130.430.08-0.47-0.22-0.04-0.030.030.0-0.04-0.230.370.29-0.47
-0.420.26-0.060.21-0.050.130.480.11-0.06-0.340.180.08-0.230.00.070.110.16-0.030.030.041.00.060.010.110.08
-0.090.050.190.140.02-0.69-0.460.730.19-0.11-0.680.840.40.03-0.22-0.360.660.030.030.130.060.130.39-0.08-0.19
0.12-0.140.19-0.12-0.050.01-0.23-0.210.190.230.02-0.040.04-0.07-0.180.14-0.30.00.040.130.040.66-0.270.7-0.18
-0.430.27-0.050.22-0.050.10.460.15-0.05-0.350.140.11-0.22-0.010.070.10.19-0.041.00.060.040.050.030.110.07
0.25-0.16-0.06-0.02-0.060.16-0.1-0.4-0.060.480.180.13-0.020.190.070.21-0.47-0.230.060.130.660.05-0.440.310.12
0.43-0.41-0.12-0.270.31-0.36-0.350.51-0.120.06-0.40.070.520.130.05-0.930.550.370.010.39-0.270.03-0.44-0.430.07
-0.280.150.530.07-0.050.080.12-0.10.53-0.260.1-0.19-0.010.01-0.50.48-0.210.290.11-0.080.70.110.31-0.43-0.46
0.290.02-0.97-0.3-0.220.260.12-0.25-0.970.440.25-0.23-0.39-0.030.97-0.13-0.05-0.470.08-0.19-0.180.070.120.07-0.46
Click cells to compare fundamentals

Extendicare Account Relationship Matchups

Extendicare fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio0.660.510.540.480.470.43
Dividend Yield0.04950.06920.06540.07290.06630.0746
Ptb Ratio6.524.656.455.86.947.29
Days Sales Outstanding21.3923.1325.0619.1425.4637.0
Book Value Per Share1.281.291.431.131.030.98
Free Cash Flow Yield(0.0178)0.0160.15(0.009284)(0.004992)(0.17)
Operating Cash Flow Per Share0.511.350.71.110.270.26
Stock Based Compensation To Revenue0.0014120.0017280.0029310.0021610.0032180.003379
Pb Ratio6.524.656.455.86.947.29
Ev To Sales1.070.850.90.660.671.08
Free Cash Flow Per Share0.130.98(0.0678)(0.0327)(1.25)(1.19)
Roic0.05490.09740.04980.04340.220.23
Inventory Turnover425.35382.86103.51423.82381.44400.51
Net Income Per Share0.320.190.470.1(0.0507)0.25
Days Of Inventory On Hand0.820.860.953.530.990.94
Payables Turnover7.647.95.725.634.736.02
Sales General And Administrative To Revenue0.03740.04230.940.950.04280.0406
Capex To Revenue0.02930.02860.05710.08320.09920.1
Cash Per Share1.062.01.161.880.890.91
Pocfratio16.654.9210.365.9226.2127.52
Interest Coverage1.823.282.081.025.175.43
Payout Ratio2.180.974.77(9.43)1.191.97
Capex To Operating Cash Flow0.730.271.11.035.565.84
Pfcf Ratio62.666.76(107.71)(200.31)(5.75)(5.46)
Days Payables Outstanding46.263.8564.877.2360.6363.66
Income Quality1.582.245.511.420.690.65
Roe0.150.330.0884(0.0448)0.390.3
Ev To Operating Cash Flow26.828.0917.178.1137.3139.18
Pe Ratio44.1314.072.89(129.44)17.9618.92
Return On Tangible Assets0.02130.04870.0112(0.00659)0.0620.0651
Ev To Free Cash Flow100.9211.13(178.58)(274.65)(8.19)(7.78)
Earnings Yield0.05060.02270.07140.0137(0.007726)0.0283
Net Debt To E B I T D A5.083.086.414.432.623.86
Current Ratio0.690.671.060.80.940.83
Tangible Book Value Per Share0.290.450.10.0409(0.43)(0.41)
Receivables Turnover17.0615.7814.5719.0714.349.98
Graham Number2.363.91.61.143.056.05
Shareholders Equity Per Share1.281.291.431.131.030.98

Pair Trading with Extendicare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Extendicare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Extendicare will appreciate offsetting losses from the drop in the long position's value.

Moving together with Extendicare Stock

  0.76BOFA Bank of AmericaPairCorr

Moving against Extendicare Stock

  0.71PFE Pfizer Inc CDRPairCorr
The ability to find closely correlated positions to Extendicare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Extendicare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Extendicare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Extendicare to buy it.
The correlation of Extendicare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Extendicare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Extendicare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Extendicare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Extendicare Stock

ExtendicareFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Extendicare investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Extendicare financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Extendicare history.